Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Valsartan associated with reduction in new onset diabetes in patients with impaired glucose tolerance
Read More »Valsartan Delays the Incidence of Microalbuminuria in Prediabetes Patients
A1C versus OGTT
Diagnosis of prediabetes for prevention of diabetes and diabetes-related complications.
Read More »HbA1c Associated with Aortic Stiffness
Progression of arterial stiffness directly linked to diabetes.
Read More »Health Benefits from Intermittent Fasting
Fasting shown to reduce risk of diabetes, heart disease, cancer and other diseases.
Read More »Adherence to Yoga May Lower Blood Glucose In Type 2 Diabetes
Yoga proven to stimulate the organs to improve metabolic activities leading to efficient chemical transformations within a cell.
Read More »Effectiveness of Invokamet in Drug-Naïve Type 2 Diabetes
Study answers question of just how effective is a SGLT-2 inhibitor with metformin.
Read More »Optimism Bias on Health Outcomes Influences Perceived Risk of Diabetes
Prediabetes, previously undiagnosed diabetes patients interviewed.
Read More »What Happens When You Have Two SGLT Inhibitors: SGLT-1 + SGLT-2 = ?
New dual drug could be a diabetes breakthrough.
Read More »Semaglutide Shows Benefits for Type 2s
Current study in Lancet showed that patients reduced their A1c levels by 1.55%.
Read More »FDA Approves Trulicity® Once Weekly Use In Combo With Daily Basal and Rapid Insulins
Only GLP-1 receptor agonist for use with mealtime or basal insulin for adults with type 2.
Read More »